Cell surface antigen in bilharzial bladder tumours.
Detection of the ABO (H) blood group in the urothelium in cases of transitional cell carcinoma of the bladder is a good indicator of the future behaviour of these tumours. Since conventional histopathological and clinical examination in bilharzial bladder carcinoma shows a clinical staging error rate of 37.2%, we used the specific red cell adherence (SRCA) technique to study the cell surface antigens in 28 patients over a 5-year period. A prediction rate of 63.6 to 84.6% was obtained when correlated with clinical behaviour.
D000017:ABO Blood-Group System / Q000276:immunology*; D000951:Antigens, Neoplasm / Q000032:analysis*; D000954:Antigens, Surface / Q000032:analysis*; D006801:Humans; D011379:Prognosis; D012553:Schistosomiasis haematobia / Q000150:complications / Q000276:immunology*; D001749:Urinary Bladder Neoplasms / Q000150:complications / Q000276:immunology*
D000017:ABO Blood-Group System; D000951:Antigens, Neoplasm; D000954:Antigens, Surface